June 28, 2016
The U.S. Food and Drug Administration illegally revoked Lannett Co. Inc.'s abbreviated new drug application for the chemotherapy drug temozolomide without due process after it was allegedly granted by mistake, the generic drugmaker claimed Tuesday in Washington, D.C., federal court.